Table 1.
Overview of the patient demographics
| MACEs group (n = 55) |
Non-MACEs group (n = 95) |
P value | Total (n = 150) |
|
|---|---|---|---|---|
| Age | 62.5 ± 9.6 | 63.8 ± 9.3 | 0.840 | 63.3 ± 9.8 |
| Female (%) | 49 (89.1) | 72 (75.8) | 0.513 | 121 (80.7) |
| BMI (kg/m2) | 25.0 ± 3.0 | 24.9 ± 2.8 | 0.920 | 25.1 ± 2.9 |
| Cardiovascular risk factors | ||||
| Hypertension (%) | 45 (81.8) | 79 (83.2) | 0.513 | 124 (82.7) |
| Diabetes (%) | 39 (70.9) | 63 (66.3) | 0.048 | 102 (68) |
| History of smoking (%) | 32 (58.2) | 41 (43.2) | 0.344 | 73 (48.7) |
| HCY(umol/L) | 15.8 ± 9.8 | 15.3 ± 8.9 | 0.569 | 19.1 ± 10.3 |
| HGB (g/L) | 148.1 ± 19.7 | 149.6 ± 15.1 | 0.863 | 148.57 ± 18.4 |
| Scr (umol/L) | 69.1 ± 11.4 | 71.0 ± 12.1 | 0.915 | 70.9 ± 11.6 |
| TG (mmol/L) | 1.47 ± 0.44 | 1.24 ± 0.28 | 0.001 | 1.36 ± 0.36 |
| TCH (mmol/L) | 4.7 ± 1.0 | 4.6 ± 1.1 | 4.6 ± 0.9 | |
| HDL-C (mmol/L) | 1.1 ± 0.2 | 1.2 ± 0.3 | 0.468 | 1.1 ± 0.3 |
| LDL-C (mmol/L) | 3.1 ± 0.9 | 3.0 ± 1.0 | 0.203 | 2.9 ± 1.0 |
| ApoA1 (g/L) | 1.1 ± 0.2 | 1.2 ± 0.1 | 0.055 | 1.15 ± 0.2 |
| ApoB (g/L) | 1.0 ± 0.2 | 1.0 ± 0.3 | 1.339 | 0.96 ± 0.3 |
| CT-FFR | 0.038 | |||
| CT-FFR ≤ 0.8 | 46 (83.6) | 58 (61.1) | 104 (69.3) | |
| CT-FFR > 0.8 | 9 (16.4) | 37 (38.9) | 46 (30.7) | |
| CDI (× 10–3/mmHg) | 3.5 ± 0.6 | 4.0 ± 0.7 | 0.003 | 3.8 ± 0.7 |
| MACEs (n = 55) | ||||
| Death | 3 (5.5) | |||
| Angina | 11 (20) | |||
| Cardiac failure | 2 (3.6) | |||
| PCI | 34 (61.8) | |||
| CABG | 5 (9) | |||
Data were expressed as mean (standard deviation) or n (%).
BMI body mass index, HDL-C high-density lipoprotein-cholesterol, HCY Homocysteine, HGB hemoglobin, Scr serum creatinine, TG triglyceride, TCH total cholesterol, LDL-C low-density lipoprotein- cholesterol, ApoA1 apolipoprotein A1, ApoB apolipoprotein B, CT-FFR computed tomography-fractional flow reserve, CDI coronary distensibility index, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting